NIH

D.C. Diagnosis Rachel Cohrs Zhang

Long Covid research gets a big-time funding boost

Politics Rachel Cohrs Zhang

Long Covid research funding at NIH gets a nearly 50% boost

Politics Sarah Owermohle

Congressmen: This Covid hearing ‘could have been an email’

D.C. Diagnosis Sarah Owermohle

STAT Plus: Health care negotiations on Capitol Hill are clear as mud

Politics Sarah Owermohle

STAT Plus: The new NIH director is walking a tightrope on Biden’s drug pricing vision

First Opinion Lynne Moronski

How to ensure the NIH’s decision to recognize people with disabilities as a health disparity population makes a difference

Special Report Sarah Owermohle

HHS’s Xavier Becerra, once an ‘invisible’ secretary, is racing to cement a clearer legacy

In the Lab Jonathan Wosen

NIH panel calls for fewer, better-paid postdocs in bid to halt loss of scientists to industry

Pharmalot Ed Silverman

STAT Plus: In response to criticism, FDA publishes new database of wayward clinical trial sponsors

Politics Sarah Owermohle

STAT Plus: Biden appoints Vanderbilt oncologist to head National Cancer Institute

Politics Sarah Owermohle

STAT Plus: House moves to limit so-called gain-of-function research

Politics Rachel Cohrs Zhang

STAT Plus: New NIH head says government has fallen behind pharma on clinical trials

Politics Sarah Owermohle

STAT Plus: Senate confirms Monica Bertagnolli as NIH director

Health tech Katie Palmer

STAT Plus: With a new center, All of Us tackles health data silos to power precision medicine

Politics Sarah Owermohle

STAT Plus: Senate committee advances Biden’s NIH nominee Monica Bertagnolli

Politics Sarah Owermohle

STAT Plus: NIH confirmation hearing highlights just how divisive the agency’s portfolio has become

Politics John Wilkerson

STAT Plus: 3 questions for the future of Biden’s cancer moonshot

Politics Sarah Owermohle and Angus Chen

STAT Plus: What to make of Biden’s latest Cancer Moonshot efforts

Politics John Wilkerson

STAT Plus: NIH nominee Bertagnolli will get a confirmation hearing next month, Sanders says

First Opinion Mark J. Ratain

The best way for the NIH to reduce drug prices is to address drug spending

Health Betsy Ladyzhets

‘Underwhelming’: NIH trials fail to test meaningful long Covid treatments — after 2.5 years and $1 billion

Politics Sarah Owermohle

Infectious disease expert Jeanne Marrazzo assumes Fauci role at NIH

Politics Rachel Cohrs Zhang

NIH begins long-delayed clinical trials for long Covid, announces new research office

Politics Sarah Owermohle

STAT Plus: A new lobby shop looks to remind Congress about NIH’s translational research arm

In the Lab Brittany Trang

STAT Plus: NIH fellows, weighing a union, want a pay raise. Will that mean less money for grants?

Politics Sarah Owermohle

STAT Plus: Biden’s NIH nominee is languishing in Congress — alarming public health advocates

Pharmalot Ed Silverman

STAT Plus: NIH halts funding for Colombian research facilities accused of abusing animals

Politics Helen Branswell

STAT Plus: House GOP inquiry over gain-of-function research targets a scientific giant

Politics Brittany Trang

STAT Plus: Doctors’ lobby doubles down on the fight against expanding open access to research